Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial

Identificador:  imarina:6388428

Handle: https://hdl.handle.net/20.500.11797/imarina6388428

Autores:  Becerra-Tomas, Nerea; Guasch-Ferre, Marta; Quilez, Joan; Merino, Jordi; Ferre, Raimon; Diaz-Lopez, Andres; Bullo, Monica; Hernandez-Alonso, Pablo; Palau-Galindo, Antoni; Salas-Salvado, Jordi

Resumen:
© 2015 Wolters Kluwer Health, Inc. All rights reserved. Because it has been suggested that food rich in g-aminobutyric acid (GABA) or angiotensin-converting enzyme inhibitor (ACEI) peptides have beneficial effects on blood pressure (BP) and other cardiovascular risk factors, we tested the effects of low-sodium bread, but rich in potassium, GABA, and ACEI peptides on 24-hour BP, glucose metabolism, and endothelial function. A randomized, double-blind, crossover trial was conducted in 30 patients with pre or mild-to-moderate hypertension, comparing three 4-week nutritional interventions separated by 2-week washout periods. Patients were randomly assigned to consume 120 g/day of 1 of the 3 types of bread for each nutritional intervention: conventional wheat bread (CB), low-sodium wheat bread enriched in potassium (LSB), and low-sodium wheat bread rich in potassium, GABA, and ACEI peptides (LSBAfter LSB Compared with the consumption of CB or LSB, no greater beneficial effects on 24-hour BP, endothelial function, or glucose metabolism were demonstrated after the consumption of LSBG in a population with pre or mild-to-moderate hypertension. Further studies are warranted to clarify the effect of GABA on BP, preferably using a specific design for noninferiority trials and ambulatory BP monitoring as a measure of BP.